Comparing the current results to its competitors, Assure Holdings reported Revenue decrease in the 2 quarter 2024 year on year by 0 %, despite the revenue increase by the most of its competitors of 3.25 %, recorded in the same quarter.
Assure Holdings Corp , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 33.22 %
Assure Holdings 's Comment on Competition and Industry Peers
The intraoperative neurophysiological monitoring (IONM) industry is highly competitive, with some competitors being larger and having well-established relationships with physicians and third-party payors. The company competes with other healthcare providers to hire and retain experienced professionals and has historically encountered challenges in attracting or retaining key personnel and securing clinical resources. Some competitors include hospitals that provide IONM services for surgeries within their facilities. Assure faces significantly larger competitors with greater marketing, financial, and other resources, which may affect its ability to compete effectively against current and future competitors.
May 16, 2024
Assure Holdings Corp Secures Nasdaq Listing Extension, Demonstrating Commitment to Compliance and GrowthDENVER, May 16, 2024 - Assure Holdings Corp. (NASDAQ: IONM), a leading provider of intraoperative neuromonitoring (IONM) and remote neurology services, has announced that it has received a written notice from the Nasdaq Listing Qualifications Panel (the Hearings Panel) granting the company an extension to regain compliance with the continued listing requirements for The Nasdaq Capital Market. This decision by the Panel affirms Assure s commitment to maintaining its NASDAQ listing and further solidifies its position as a key player in the healthcare technology sector.The Hearings Panel has granted Assure an...
Accuray Incorporated is a medical technology company that focuses on the development and sale of radiation therapy systems. Their business model revolves around providing advanced and precise treatment options to cancer patients by combining robotics and imaging technologies. By delivering innovative solutions, Accuray aims to improve patient outcomes and establish partnerships with healthcare providers worldwide.
ViewRay Inc's business model revolves around the development and commercialization of advanced radiation therapy systems, primarily the MRIdian system, which combines magnetic resonance imaging (MRI) technology with radiation therapy to enhance precision and accuracy in cancer treatment.
American Shared Hospital Services Share Performance
-1.70%
This Quarter
American Shared Hospital Services
Profile
American Shared Hospital Services (ASHS) operates a unique business model by providing state-of-the-art medical equipment on a shared basis to hospitals and medical centers across the United States. They establish partnerships with healthcare providers, offering the latest technology for radiation therapy, radiosurgery, and nuclear medicine without the need for significant capital investments. By leveraging their expertise and established relationships in the healthcare industry, ASHS delivers cost-effective solutions that benefit both patients and healthcare facilities alike.
Masimo Corp is a medical technology company that focuses on developing and manufacturing innovative monitoring devices for patient care. Their business model revolves around creating and selling advanced noninvasive monitoring solutions to healthcare providers worldwide. They also generate revenue through licensing agreements, providing maintenance and support services, and selling disposable products and accessories related to their monitoring devices.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Sources:
Assure Holdings Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Assure Holdings Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
